How Our Buy-Side Experience Changes the Way We Do Research
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-CW-4.png)
The difference between making a trade and publishing an idea is much larger than most analysts think. We’ve been there. We know it matters.
Hedge Funds and the Importance of Covering Shorts
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-ML-2.png)
A thorough and balanced process should, over time, deliver at least as many Short recommendations as Long
What Does Independence Mean and How Does It Impact Our Research?
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-CW-3.png)
We cannot promise to always be right, but our clients should feel confident they are getting our authentic view.
Why Short Research is Important to Financial Advisors and Wealth Managers
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-ML-3.png)
Whether you run discretionary mandates for your clients, advise them on managing their own funds, or recommend others’ funds – your clients rely on you for their investment decisions.
Why Do We Aim to Identify Doubles and Halves?
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-CW-2.png)
Our analysis suggests that over the cycle ~9% of European stocks double and ~14% halve within a two year period.
Why Short Research Helps You Manage Your Portfolio Risk
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-ML-4.png)
Our analysis suggests that over the cycle ~9% of European stocks double and ~14% halve within a two year period
Why Does Our Short Research Make Our Long Analysis Better?
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-CW-1.png)
When did you last read a research report that said “Buy, because the accounts are really clean and governance is text book?”
Why Differentiated Ideas are Essential to Long-Only Funds
![](https://theanalyst.co.uk/wp-content/uploads/2019/04/NBD-ML-1.png)
95% of research being consumed by the buyside coming from a handful of conflicted providers with a propensity to deliver Buy recommendations and not to fully assess downside risks.